Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Women'S Health (London, England)|October 6, 2020
The role of aspirin in the prevention of ovarian, endometrial and cervical cancersNalinie Joharatnam-Hogan, Fay H Cafferty, Archie Macnair, et al.Trials|May 11, 2021
Accessing routinely collected health data to improve clinical trials: recent experience of accessArchie Macnair, Sharon B Love, Macey L Murray, et al.Ecancermedicalscience|April 17, 2013
Clinical evidence for the use of aspirin in the treatment of cancerRuth E LangleyStatistical Methods in Medical Research|September 4, 2008
A deterministic model for estimating the reduction in colorectal cancer incidence due to endoscopic surveillanceFay H Cafferty, Peter D Sasieni, Stephen W DuffyContemporary Clinical Trials|October 30, 2016
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumoursChristopher Coyle, Fay H Cafferty, Samuel Rowley, et al.Journal of Medical Screening|December 15, 2007
Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening TrialJack Cuzick, Fay H Cafferty, Robert Edwards, et al.The Lancet. Oncology|June 12, 2010
Potential pitfalls in the design and reporting of clinical trialsMatthew R Sydes, Ruth E LangleyNature Reviews. Clinical Oncology|December 5, 2012
Potential biomarker for aspirin use in colorectal cancer therapyRuth E Langley, Peter M RothwellCurrent Opinion in Oncology|May 21, 2014
Aspirin in gastrointestinal oncology: new data on an old friendRuth E Langley, Peter M RothwellClinical Trials (London, England)|August 24, 2017
Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocolsMahesh Kb Parmar, Matthew R Sydes, Fay H Cafferty, et al.Pageof 9